| Ytd | -29.11% | |
| 1y | -32.24% |
| Open | 0.41 | Prev Close | 0.41 | Low | 0.39 | High | 0.42 | Mkt Cap | 13.24M |
| Vol | 403.51K | Avg Vol | 869.05K | EPS | -2.19 | P/E | -0.18 | Forward P/E | N/A |
| Beta | 0.56 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.40 | 200-d Avg | 0.53 | 1yr Est | 0.00 |
OSRH News
Founder and CEO addresses the Company's Nasdaq listing status and accelerating subsidiary business d
BELLEVUE, WA / ACCESS Newswire / August 7, 2026 / OSR Health, Inc. (NASDAQ:OSRH) ("OSR Health" or th
OSR Health, Inc. (NASDAQ:OSRH) today announced that its subsidiary Vaximm AG has completed the analy
Encouraging data from two glioblastoma studies are expected to be submitted for publication in the c
BELLEVUE, WA / ACCESS Newswire / July 31, 2026 / OSR Health, Inc. (NASDAQ:OSRH) ("OSR Health" or the
BELLEVUE, WA / ACCESS Newswire / July 13, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the f
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark
NEW YORK CITY, NY / ACCESS Newswire / July 2, 2026 / Emerging Growth Research today issued a flash r
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
Contingent Value Rights would reward continuous holders with additional shares as the Company meets
BELLEVUE, WA / ACCESS Newswire / June 22, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced th
BELLEVUE, WA / ACCESS Newswire / June 3, 2026 / Dear Fellow Shareholders, As we move through 2026, I
Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level BEL
A Clear Commitment: No Reverse Stock Split BELLEVUE, WA / ACCESS Newswire / May 12, 2026 / As many o
NEW YORK, NY / ACCESS Newswire / May 5, 2026 / Emerging Growth Research today issued a flash report
OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026 BELLEVUE
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
Largest shareholder pledges entire equity stake as collateral for milestone obligations, reinforcing
BELLEVUE, WA / ACCESS Newswire / April 9, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) ("OSR Holdings" or
BELLEVUE, WA / ACCESS Newswire / March 30, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global healthc
NEW YORK CITY, NY / ACCESS Newswire / March 27, 2026 / Emerging Growth Research today issued a flash
BELLEVUE, WA / ACCESS Newswire / March 23, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH) today announced a
BELLEVUE, WA / ACCESS Newswire / March 19, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a healthcare-foc
BELLEVUE, WASHINGTON / ACCESS Newswire / March 5, 2026 / OSR Holdings, Inc. (NASDAQ:OSRH), a global
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market ses